Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Global Microarray Analysis Market - A Global and Regional Analysis: Focus on Product, Type, Application, End User, Region, Country Level Analysis and ...

The expectation that microarray technology will play a large role in shaping the future of pharmaceutical development and diagnostics has increased due to new products and applications. Microarrays ...

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...

High-Throughput and Multiplexed Assays Augment Biomarker Discovery and Diagnostics High-throughput proteomics using microarray-based technology and proteome chips is accelerating protein-biomarker ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...

Companies in the microarray sector are trying to take the technology out of core facilities and put it into the hands of individual researchers by developing technologies such as smaller, less-costly ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...